{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:49:43Z","timestamp":1792010983142,"version":"4.4.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,2]]},"DOI":"10.7759\/cureus.59532","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T13:16:29Z","timestamp":1714655789000},"source":"Crossref","is-referenced-by-count":14,"title":["Adherence to Antihypertensive Therapy and Its Determinants: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Pedro D","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A","family":"Simoes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise C","family":"Velho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. Cardiovascular diseases (CVDs). (2021). Accessed. December 8, 2021: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)?gad_source=1&amp;gclid=Cj0KCQjw2uiwBhCXAR...."},{"key":"ref2","unstructured":"OECD. Health at a glance 2021. OECD indicators. (2021). Accessed: December 8, 2021: https:\/\/www.oecd-ilibrary.org\/social-issues-migration-health\/health-at-a-glance-2021_ae3016b9-en."},{"key":"ref3","article-title":"Trends in life expectancy in EU and other OECD countries: why are improvements slowing?","volume":"108","author":"Raleigh V","year":"2019","unstructured":"Raleigh V. Trends in life expectancy in EU and other OECD countries: why are improvements slowing?. OECD Health Work Pap. 2019, 108:24-6.","journal-title":"OECD Health Work Pap"},{"key":"ref4","unstructured":"National Statistics Institute (site in Portuguese). (Estat\u00edsticas da Sa\u00fade). Accessed. December 17, 2021: https:\/\/www.ine.pt\/ngt_server\/attachfileu.jsp?look_parentBoui=492336067&amp;att_display=n&amp;att_download=y."},{"key":"ref5","unstructured":"Directorate-General for Health. National program for cerebrovascular diseases (site in Portuguese). (2017). Accessed. December 17, 2021: https:\/\/comum.rcaap.pt\/handle\/10400.26\/21114."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000162","article-title":"Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal: changes over a decade. The PHYSA study","volume":"32","author":"Polonia J","year":"2014","unstructured":"Polonia J, Martins L, Pinto F, Nazare J. Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal: changes over a decade. The PHYSA study. J Hypertens. 2014, 32:1211-21. 10.1097\/HJH.0000000000000162","journal-title":"J Hypertens"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","year":"2021","unstructured":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019. a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021, 398:957-80. 10.1016\/S0140-6736(21)01330-1","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","article-title":"High blood pressure and cardiovascular disease","volume":"75","author":"Fuchs FD","year":"2020","unstructured":"Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020, 75:285-92. 10.1161\/HYPERTENSIONAHA.119.14240","journal-title":"Hypertension"},{"key":"ref9","unstructured":"WHO. Hypertension and COVID-19. scientific brief. (2021). Accessed: December 17, 2021: https:\/\/iris.who.int\/bitstream\/handle\/10665\/341848\/WHO-2019-nCoV-Sci-Brief-Hypertension-2021.1-eng.pdf?sequence=1."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"Richardson S","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, et al.. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020, 323:2052-9. 10.1001\/jama.2020.6775","journal-title":"JAMA"},{"key":"ref11","unstructured":"National Statistics Institute. 2014 National Health Survey (site in Portuguese). (2014). Accessed. December 17, 2021: https:\/\/www.ine.pt\/xportal\/xmain?xpid=INE&amp;xpgid=ine_publicacoes&amp;PUBLICACOESpub_boui=263714091&amp;PUBLICACOESmodo=2."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams B","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, et al.. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018, 39:3021-104. 10.1093\/eurheartj\/ehy339","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00559-8","article-title":"Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension","volume":"18","author":"Zhou B","year":"2021","unstructured":"Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021, 18:785-802. 10.1038\/s41569-021-00559-8","journal-title":"Nat Rev Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000378","article-title":"Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials","volume":"32","author":"Thomopoulos C","year":"2014","unstructured":"Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. J Hypertens. 2014, 32:2285-95. 10.1097\/HJH.0000000000000378","journal-title":"J Hypertens"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.repc.2019.05.009","article-title":"Implications for medical activity of differences between individuals with controlled and uncontrolled hypertension","volume":"38","author":"Martins RD","year":"2019","unstructured":"Martins RD, Santiago LM, Reis MT, Roque AC, Pinto M, Sim\u00f5es JA, Rosendo I. Implications for medical activity of differences between individuals with controlled and uncontrolled hypertension. Rev Port Cardiol (Engl Ed). 2019, 38:745-53. 10.1016\/j.repc.2019.05.009","journal-title":"Rev Port Cardiol (Engl Ed)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000045","article-title":"Managing 'resistance': is adherence a target for treatment?","volume":"23","author":"Burnier M","year":"2014","unstructured":"Burnier M. Managing 'resistance': is adherence a target for treatment?. Curr Opin Nephrol Hypertens. 2014, 23:439-43. 10.1097\/MNH.0000000000000045","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005641","article-title":"Nonadherence to antihypertensive drugs: a systematic review and meta-analysis","volume":"96","author":"Abegaz TM","year":"2017","unstructured":"Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS, Elnour AA. Nonadherence to antihypertensive drugs: a systematic review and meta-analysis. Medicine (Baltimore). 2017, 96:e5641. 10.1097\/MD.0000000000005641","journal-title":"Medicine (Baltimore)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-5151(03)00091-4","article-title":"Adherence to long-term therapies: evidence for action","volume":"2","author":"De Geest S","year":"2003","unstructured":"De Geest S, Sabat\u00e9 E. Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs. 2003, 2:323. 10.1016\/S1474-5151(03)00091-4","journal-title":"Eur J Cardiovasc Nurs"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.02893.x","article-title":"Compliance, concordance, adherence","volume":"63","author":"Aronson JK","year":"2007","unstructured":"Aronson JK. Compliance, concordance, adherence. Br J Clin Pharmacol. 2007, 63:383-4. 10.1111\/j.1365-2125.2007.02893.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0575","article-title":"Medication adherence: WHO cares?","volume":"86","author":"Brown MT","year":"2011","unstructured":"Brown MT, Bussell JK. Medication adherence: WHO cares?. Mayo Clin Proc. 2011, 86:304-14. 10.4065\/mcp.2010.0575","journal-title":"Mayo Clin Proc"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.aprim.2019.06.001","article-title":"Effects of changing the appearance of medications in safety and adherence in chronic patients over 65 years of age in primary care. CAMBIMED Study (Article in Spanish)","volume":"52","author":"Aranc\u00f3n-Monge JM","year":"2020","unstructured":"Aranc\u00f3n-Monge JM, de Castro-Cuenca A, Serrano-V\u00e1zquez \u00c1, Campos-D\u00edaz L, Rodr\u00edguez Barrientos R, Del Cura-Gonz\u00e1lez I. Effects of changing the appearance of medications in safety and adherence in chronic patients over 65 years of age in primary care. CAMBIMED Study (Article in Spanish). Aten Primaria. 2020, 52:77-85. 10.1016\/j.aprim.2019.06.001","journal-title":"Aten Primaria"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13706","article-title":"Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence","volume":"84","author":"Avataneo V","year":"2018","unstructured":"Avataneo V, De Nicol\u00f2 A, Rabbia F, et al.. Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. Br J Clin Pharmacol. 2018, 84:2535-43. 10.1111\/bcp.13706","journal-title":"Br J Clin Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.12957\/reuerj.2019.45894","article-title":"Factors associated with adherence of adults\/elderly people to the treatment of arterial hypertension in primary care (Article in Portuguese)","volume":"27","author":"Barbosa MEM","year":"2019","unstructured":"Barbosa MEM, Bertelli EVM, Aggio CdM, Scolari GAdS, Marcon SS, Carreira L. Factors associated with adherence of adults\/elderly people to the treatment of arterial hypertension in primary care (Article in Portuguese). Rev Enferm UERJ. 2019, 27:2-4. 10.12957\/reuerj.2019.45894","journal-title":"Rev Enferm UERJ"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13312","article-title":"Impact of adverse drug events and treatment satisfaction on patient adherence with antihypertensive medication - a study in ambulatory patients","volume":"83","author":"Berhe DF","year":"2017","unstructured":"Berhe DF, Taxis K, Haaijer-Ruskamp FM, Mulugeta A, Mengistu YT, Burgerhof JG, Mol PG. Impact of adverse drug events and treatment satisfaction on patient adherence with antihypertensive medication - a study in ambulatory patients. Br J Clin Pharmacol. 2017, 83:2107-17. 10.1111\/bcp.13312","journal-title":"Br J Clin Pharmacol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16071226","article-title":"Impact of a culturally tailored mHealth medication regimen self-management program upon blood pressure among hypertensive Hispanic adults","volume":"16","author":"Chandler J","year":"2019","unstructured":"Chandler J, Sox L, Kellam K, Feder L, Nemeth L, Treiber F. Impact of a culturally tailored mHealth medication regimen self-management program upon blood pressure among hypertensive Hispanic adults. Int J Environ Res Public Health. 2019, 16:4-6. 10.3390\/ijerph16071226","journal-title":"Int J Environ Res Public Health"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019943","article-title":"Association between patient-clinician relationships and adherence to antihypertensive medications among black adults: an observational study design","volume":"10","author":"Chang TJ","year":"2021","unstructured":"Chang TJ, Bridges JF, Bynum M, et al.. Association between patient-clinician relationships and adherence to antihypertensive medications among black adults: an observational study design. J Am Heart Assoc. 2021, 10:e019943. 10.1161\/JAHA.120.019943","journal-title":"J Am Heart Assoc"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29974-7","article-title":"Association between cognitive impairment and poor antihypertensive medication adherence in elderly hypertensive patients without dementia","volume":"8","author":"Cho MH","year":"2018","unstructured":"Cho MH, Shin DW, Chang SA, et al.. Association between cognitive impairment and poor antihypertensive medication adherence in elderly hypertensive patients without dementia. Sci Rep. 2018, 8:11688. 10.1038\/s41598-018-29974-7","journal-title":"Sci Rep"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018986","article-title":"Implicit and explicit attitudes toward antihypertensive medications explain variation in pharmacy refill and self-reported adherence beyond traditional risk factors: potential novel mechanism underlying adherence","volume":"10","author":"Craig LS","year":"2021","unstructured":"Craig LS, Peacock E, Mohundro BL, et al.. Implicit and explicit attitudes toward antihypertensive medications explain variation in pharmacy refill and self-reported adherence beyond traditional risk factors: potential novel mechanism underlying adherence. J Am Heart Assoc. 2021, 10:e018986. 10.1161\/JAHA.120.018986","journal-title":"J Am Heart Assoc"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s40292-021-00465-7","article-title":"Real-world antihypertensive treatment patterns, treatment adherence, and blood pressure control in the elderly: an Italian awareness-raising campaign on hypertension by senior Italia FederAnziani, the Italian Society of Hypertension and the Italian Federation of General Practitioners","volume":"28","author":"Del Pinto R","year":"2021","unstructured":"Del Pinto R, Desideri G, Ferri C, Agabiti Rosei E. Real-world antihypertensive treatment patterns, treatment adherence, and blood pressure control in the elderly: an Italian awareness-raising campaign on hypertension by senior Italia FederAnziani, the Italian Society of Hypertension and the Italian Federation of General Practitioners. High Blood Press Cardiovasc Prev. 2021, 28:457-66. 10.1007\/s40292-021-00465-7","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/bjhp.12332","article-title":"Medication adherence for resistant hypertension: assessing theoretical predictors of adherence using direct and indirect adherence measures","volume":"23","author":"Durand H","year":"2018","unstructured":"Durand H, Hayes P, Harhen B, et al.. Medication adherence for resistant hypertension: assessing theoretical predictors of adherence using direct and indirect adherence measures. Br J Health Psychol. 2018, 23:949-66. 10.1111\/bjhp.12332","journal-title":"Br J Health Psychol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpaa072","article-title":"Association between cost-related medication nonadherence and hypertension management among US adults","volume":"33","author":"Fang J","year":"2020","unstructured":"Fang J, Chang T, Wang G, Loustalot F. Association between cost-related medication nonadherence and hypertension management among US adults. Am J Hypertens. 2020, 33:879-86. 10.1093\/ajh\/hpaa072","journal-title":"Am J Hypertens"},{"key":"ref32","article-title":"Factors related with non-adherence to pharmacological treatment in hypertensive patients of the \"Policlinico XX Aniversario\". An educational program design","volume":"9","author":"Fernandez J","year":"2017","unstructured":"Fernandez J, Mota CD, Tandron JMC, Ferrer YB, Esmores ZA. Factors related with non-adherence to pharmacological treatment in hypertensive patients of the \"Policlinico XX Aniversario\". An educational program design. Revista de Enferm Cardiovasc. 2017, 9:18-20.","journal-title":"Revista de Enferm Cardiovasc"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpx200","article-title":"Patient experience with care and its association with adherence to hypertension medications","volume":"31","author":"Fortuna RJ","year":"2018","unstructured":"Fortuna RJ, Nagel AK, Rocco TA, Legette-Sobers S, Quigley DD. Patient experience with care and its association with adherence to hypertension medications. Am J Hypertens. 2018, 31:340-5. 10.1093\/ajh\/hpx200","journal-title":"Am J Hypertens"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpaa111","article-title":"A clinical prediction model of medication adherence in hypertensive patients in a Chinese community hospital in Beijing","volume":"33","author":"Gao W","year":"2020","unstructured":"Gao W, Liu H, Ge C, Liu X, Jia H, Wu H, Peng X. A clinical prediction model of medication adherence in hypertensive patients in a Chinese community hospital in Beijing. Am J Hypertens. 2020, 33:1038-46. 10.1093\/ajh\/hpaa111","journal-title":"Am J Hypertens"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1590\/0103-1104201811614","article-title":"Adherence to pharmacological treatment of arterial hypertension in primary health care (Article in Portuguese)","volume":"42","author":"Gewehr DM","year":"2018","unstructured":"Gewehr DM, Bandeira VA, Gelatti GT, Colet C, Oliveira KR. Adherence to pharmacological treatment of arterial hypertension in primary health care (Article in Portuguese). Sa\u00fade Debate. 2018, 42:179-90. 10.1590\/0103-1104201811614","journal-title":"Sa\u00fade Debate"},{"key":"ref36","article-title":"Predictors of poor adherence to hypertension treatment","volume":"97","author":"Gniwa Omezzine R","year":"2019","unstructured":"Gniwa Omezzine R, Akkara A, Abdelkafi Koubaa A, Belguith Sriha A, Rdissi A, Amamou K. Predictors of poor adherence to hypertension treatment. Tunis Med. 2019, 97:564-71.","journal-title":"Tunis Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.09631","article-title":"Biochemical screening for nonadherence is associated with blood pressure reduction and improvement in adherence","volume":"70","author":"Gupta P","year":"2017","unstructured":"Gupta P, Patel P, \u0160trauch B, et al.. Biochemical screening for nonadherence is associated with blood pressure reduction and improvement in adherence. Hypertension. 2017, 70:1042-8. 10.1161\/HYPERTENSIONAHA.117.09631","journal-title":"Hypertension"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.08729","article-title":"Risk factors for nonadherence to antihypertensive treatment","volume":"69","author":"Gupta P","year":"2017","unstructured":"Gupta P, Patel P, \u0160trauch B, et al.. Risk factors for nonadherence to antihypertensive treatment. Hypertension. 2017, 69:1113-20. 10.1161\/HYPERTENSIONAHA.116.08729","journal-title":"Hypertension"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpx086","article-title":"Antihypertensive adherence trajectories among older adults in the first year after initiation of therapy","volume":"30","author":"Hargrove JL","year":"2017","unstructured":"Hargrove JL, Pate V, Casteel CH, Golightly YM, Loehr LR, Marshall SW, St\u00fcrmer T. Antihypertensive adherence trajectories among older adults in the first year after initiation of therapy. Am J Hypertens. 2017, 30:1015-23. 10.1093\/ajh\/hpx086","journal-title":"Am J Hypertens"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S245052","article-title":"Gender differences in the associations between health literacy and medication adherence in hypertension: a population-based survey in Heris County, Iran","volume":"16","author":"Heizomi H","year":"2020","unstructured":"Heizomi H, Iraji Z, Vaezi R, Bhalla D, Morisky DE, Nadrian H. Gender differences in the associations between health literacy and medication adherence in hypertension: a population-based survey in Heris County, Iran. Vasc Health Risk Manag. 2020, 16:157-66. 10.2147\/VHRM.S245052","journal-title":"Vasc Health Risk Manag"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-018-0127-0","article-title":"Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database","volume":"42","author":"Ishida T","year":"2019","unstructured":"Ishida T, Oh A, Hiroi S, Shimasaki Y, Nishigaki N, Tsuchihashi T. Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database. Hypertens Res. 2019, 42:249-56. 10.1038\/s41440-018-0127-0","journal-title":"Hypertens Res"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-029862","article-title":"Effects of combination drugs on antihypertensive medication adherence in a real-world setting: a Korean nationwide study","volume":"9","author":"Kim SJ","year":"2019","unstructured":"Kim SJ, Kwon OD, Cho B, Oh SW, Lee CM, Choi HC. Effects of combination drugs on antihypertensive medication adherence in a real-world setting: a Korean nationwide study. BMJ Open. 2019, 9:e029862. 10.1136\/bmjopen-2019-029862","journal-title":"BMJ Open"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024654","article-title":"Nonadherence to antihypertensive medications amongst patients with uncontrolled hypertension: A retrospective study","volume":"100","author":"Kulkarni S","year":"2021","unstructured":"Kulkarni S, Rao R, Goodman JD, Connolly K, O'Shaughnessy KM. Nonadherence to antihypertensive medications amongst patients with uncontrolled hypertension: A retrospective study. Medicine (Baltimore). 2021, 100:e24654. 10.1097\/MD.0000000000024654","journal-title":"Medicine (Baltimore)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-016-3972-z","article-title":"Effect of combination therapy on adherence among US patients initiating therapy for hypertension: a cohort study","volume":"32","author":"Lauffenburger JC","year":"2017","unstructured":"Lauffenburger JC, Landon JE, Fischer MA. Effect of combination therapy on adherence among US patients initiating therapy for hypertension: a cohort study. J Gen Intern Med. 2017, 32:619-25. 10.1007\/s11606-016-3972-z","journal-title":"J Gen Intern Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219266","article-title":"Factors associated with poor adherence to medication among hypertensive patients in twelve low and middle-income Sub-Saharan countries","volume":"14","author":"Macquart de Terline D","year":"2019","unstructured":"Macquart de Terline D, Kane A, Kramoh KE, et al.. Factors associated with poor adherence to medication among hypertensive patients in twelve low and middle-income Sub-Saharan countries. PLoS One. 2019, 14:e0219266. 10.1371\/journal.pone.0219266","journal-title":"PLoS One"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.0447","article-title":"Association of a smartphone application with medication adherence and blood pressure control: the MedISAFE-BP randomized clinical trial","volume":"178","author":"Morawski K","year":"2018","unstructured":"Morawski K, Ghazinouri R, Krumme A, et al.. Association of a smartphone application with medication adherence and blood pressure control: the MedISAFE-BP randomized clinical trial. JAMA Intern Med. 2018, 178:802-9. 10.1001\/jamainternmed.2018.0447","journal-title":"JAMA Intern Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1590\/0034-7167-2020-0173","article-title":"Factors associated to the adherence to the non-pharmachological treatment of hypertension in primary health care","volume":"74","author":"Nascimento MO","year":"2021","unstructured":"Nascimento MO, Belo RM, Ara\u00fajo TL, Silva KG, Barros MD, Figueir\u00eado TR, Bezerra SM. Factors associated to the adherence to the non-pharmachological treatment of hypertension in primary health care. Rev Bras Enferm. 2021, 74:e20200173. 10.1590\/0034-7167-2020-0173","journal-title":"Rev Bras Enferm"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-017-6756-8","article-title":"Assessing adherence to antihypertensive therapy in primary health care in Namibia: findings and implications","volume":"31","author":"Nashilongo MM","year":"2017","unstructured":"Nashilongo MM, Singu B, Kalemeera F, et al.. Assessing adherence to antihypertensive therapy in primary health care in Namibia: findings and implications. Cardiovasc Drugs Ther. 2017, 31:565-78. 10.1007\/s10557-017-6756-8","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-020-0440-2","article-title":"Adherence to antihypertensive medication and its predictors among non-elderly adults in Japan","volume":"43","author":"Nishimura S","year":"2020","unstructured":"Nishimura S, Kumamaru H, Shoji S, Sawano M, Kohsaka S, Miyata H. Adherence to antihypertensive medication and its predictors among non-elderly adults in Japan. Hypertens Res. 2020, 43:705-14. 10.1038\/s41440-020-0440-2","journal-title":"Hypertens Res"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.48139","article-title":"Impact of patient knowledge on hypertension treatment adherence and efficacy: a single-centre study in Poland","volume":"18","author":"Paczkowska A","year":"2021","unstructured":"Paczkowska A, Hoffmann K, Kus K, et al.. Impact of patient knowledge on hypertension treatment adherence and efficacy: a single-centre study in Poland. Int J Med Sci. 2021, 18:852-60. 10.7150\/ijms.48139","journal-title":"Int J Med Sci"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016116","article-title":"Determinants of hypertension treatment adherence among a Chinese population using the therapeutic adherence scale for hypertensive patients","volume":"98","author":"Pan J","year":"2019","unstructured":"Pan J, Wu L, Wang H, Lei T, Hu B, Xue X, Li Q. Determinants of hypertension treatment adherence among a Chinese population using the therapeutic adherence scale for hypertensive patients. Medicine (Baltimore). 2019, 98:e16116. 10.1097\/MD.0000000000016116","journal-title":"Medicine (Baltimore)"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17186789","article-title":"Acceptance of illness and compliance with therapeutic recommendations in patients with hypertension","volume":"17","author":"Pluta A","year":"2020","unstructured":"Pluta A, Sulikowska B, Manitius J, Posieczek Z, Marzec A, Morisky DE. Acceptance of illness and compliance with therapeutic recommendations in patients with hypertension. Int J Environ Res Public Health. 2020, 17:42-4. 10.3390\/ijerph17186789","journal-title":"Int J Environ Res Public Health"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpab083","article-title":"Adherence to treatment by initial antihypertensive mono and combination therapies","volume":"34","author":"Rea F","year":"2021","unstructured":"Rea F, Savar\u00e9 L, Franchi M, Corrao G, Mancia G. Adherence to treatment by initial antihypertensive mono and combination therapies. Am J Hypertens. 2021, 34:1083-91. 10.1093\/ajh\/hpab083","journal-title":"Am J Hypertens"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.117.003659","article-title":"Addressing the social needs of hypertensive patients: the role of patient-provider communication as a predictor of medication adherence","volume":"10","author":"Schoenthaler A","year":"2017","unstructured":"Schoenthaler A, Knafl GJ, Fiscella K, Ogedegbe G. Addressing the social needs of hypertensive patients: the role of patient-provider communication as a predictor of medication adherence. Circ Cardiovasc Qual Outcomes. 2017, 10:32-4. 10.1161\/CIRCOUTCOMES.117.003659","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1111\/jch.13475","article-title":"Adherence to oral antihypertensive medications, are all medications equal?","volume":"21","author":"Shani M","year":"2019","unstructured":"Shani M, Lustman A, Vinker S. Adherence to oral antihypertensive medications, are all medications equal?. J Clin Hypertens (Greenwich). 2019, 21:243-8. 10.1111\/jch.13475","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00822","article-title":"Association between medication literacy and medication adherence among patients with hypertension","volume":"10","author":"Shi S","year":"2019","unstructured":"Shi S, Shen Z, Duan Y, Ding S, Zhong Z. Association between medication literacy and medication adherence among patients with hypertension. Front Pharmacol. 2019, 10:822. 10.3389\/fphar.2019.00822","journal-title":"Front Pharmacol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249222","article-title":"Magnitude and associated factors of poor medication adherence among diabetic and hypertensive patients visiting public health facilities in Ethiopia during the COVID-19 pandemic","volume":"16","author":"Shimels T","year":"2021","unstructured":"Shimels T, Asrat Kassu R, Bogale G, et al.. Magnitude and associated factors of poor medication adherence among diabetic and hypertensive patients visiting public health facilities in Ethiopia during the COVID-19 pandemic. PLoS One. 2021, 16:e0249222. 10.1371\/journal.pone.0249222","journal-title":"PLoS One"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4850","article-title":"A concept-wide association study to identify potential risk factors for nonadherence among prevalent users of antihypertensives","volume":"28","author":"Singh K","year":"2019","unstructured":"Singh K, Choudhry NK, Krumme AA, McKay C, McElwee NE, Kimura J, Franklin JM. A concept-wide association study to identify potential risk factors for nonadherence among prevalent users of antihypertensives. Pharmacoepidemiol Drug Saf. 2019, 28:1299-308. 10.1002\/pds.4850","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12979","article-title":"Adherence to triple-component antihypertensive regimens is higher with single-pill than equivalent two-pill regimens: a randomized controlled trial","volume":"14","author":"Sung J","year":"2021","unstructured":"Sung J, Ahn KT, Cho BR, et al.. Adherence to triple-component antihypertensive regimens is higher with single-pill than equivalent two-pill regimens: a randomized controlled trial. Clin Transl Sci. 2021, 14:1185-92. 10.1111\/cts.12979","journal-title":"Clin Transl Sci"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.12495","article-title":"Antihypertensive medication nonpersistence and low adherence for adults <65 years initiating treatment in 2007-2014","volume":"74","author":"Tajeu GS","year":"2019","unstructured":"Tajeu GS, Kent ST, Huang L, et al.. Antihypertensive medication nonpersistence and low adherence for adults &lt;65 years initiating treatment in 2007-2014. Hypertension. 2019, 74:35-46. 10.1161\/HYPERTENSIONAHA.118.12495","journal-title":"Hypertension"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/jch.13098","article-title":"Mobile phone text messaging improves antihypertensive drug adherence in the community","volume":"19","author":"Varleta P","year":"2017","unstructured":"Varleta P, Acevedo M, Akel C, et al.. Mobile phone text messaging improves antihypertensive drug adherence in the community. J Clin Hypertens (Greenwich). 2017, 19:1276-84. 10.1111\/jch.13098","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref62","article-title":"Depressive disorders and life events in patients with arterial hypertension and their relationship with therapeutic adherence (Article in Spanish)","volume":"23","author":"V\u00e1zquez Machado A","year":"2019","unstructured":"V\u00e1zquez Machado A, Mukamutara J, Meireles Ochoa MY, et al.. Depressive disorders and life events in patients with arterial hypertension and their relationship with therapeutic adherence (Article in Spanish). Multimed. 2019, 23:1079-94.","journal-title":"Multimed"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.31744\/einstein_journal\/2021AO6011","article-title":"The use of an electronic medication organizer device with alarm to improve medication adherence of older adults with hypertension","volume":"19","author":"Vieira LB","year":"2021","unstructured":"Vieira LB, Reis AM, Ramos C\u00c1, Reis TM, Cassiani SH. The use of an electronic medication organizer device with alarm to improve medication adherence of older adults with hypertension. Einstein (Sao Paulo). 2021, 19:eAO6011. 10.31744\/einstein_journal\/2021AO6011","journal-title":"Einstein (Sao Paulo)"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252944","article-title":"Effect of number of medications and complexity of regimens on medication adherence and blood pressure management in hospitalized patients with hypertension","volume":"16","author":"Wakai E","year":"2021","unstructured":"Wakai E, Ikemura K, Kato C, Okuda M. Effect of number of medications and complexity of regimens on medication adherence and blood pressure management in hospitalized patients with hypertension. PLoS One. 2021, 16:e0252944. 10.1371\/journal.pone.0252944","journal-title":"PLoS One"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1111\/jch.13265","article-title":"The effect of a practice-based multicomponent intervention that includes health coaching on medication adherence and blood pressure control in rural primary care","volume":"20","author":"Wu JR","year":"2018","unstructured":"Wu JR, Cummings DM, Li Q, Hinderliter A, Bosworth HB, Tillman J, DeWalt D. The effect of a practice-based multicomponent intervention that includes health coaching on medication adherence and blood pressure control in rural primary care. J Clin Hypertens (Greenwich). 2018, 20:757-64. 10.1111\/jch.13265","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002294","article-title":"Medication adherence in hypertension","volume":"38","author":"Poulter NR","year":"2020","unstructured":"Poulter NR, Borghi C, Parati G, Pathak A, Toli D, Williams B, Schmieder RE. Medication adherence in hypertension. J Hypertens. 2020, 38:579-87. 10.1097\/HJH.0000000000002294","journal-title":"J Hypertens"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2017.48","article-title":"Factors associated with antihypertensive medication non-adherence: a systematic review","volume":"31","author":"van der Laan DM","year":"2017","unstructured":"van der Laan DM, Elders PJ, Boons CC, Beckeringh JJ, Nijpels G, Hugtenburg JG. Factors associated with antihypertensive medication non-adherence: a systematic review. J Hum Hypertens. 2017, 31:687-94. 10.1038\/jhh.2017.48","journal-title":"J Hum Hypertens"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.32385\/rpmgf.v37i4.12951","article-title":"Therapeutic adherence in hypertensive patients: review of the role of new platforms via cell phone or smartphone (Article in Portuguese)","volume":"37","author":"Loureiro RM","year":"2021","unstructured":"Loureiro RM, de Azevedo DA. Therapeutic adherence in hypertensive patients: review of the role of new platforms via cell phone or smartphone (Article in Portuguese). Portuguese J Family Med and Gen Pract. 2021, 37:330-41. 10.32385\/rpmgf.v37i4.12951","journal-title":"Portuguese J Family Med and Gen Pract"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9021017","article-title":"Mobile phone-based intervention in hypertension management","volume":"2019","author":"Andre N","year":"2019","unstructured":"Andre N, Wibawanti R, Siswanto BB. Mobile phone-based intervention in hypertension management. Int J Hypertens. 2019, 2019:9021017. 10.1155\/2019\/9021017","journal-title":"Int J Hypertens"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcw018","article-title":"The role of mHealth for improving medication adherence in patients with cardiovascular disease: a systematic review","volume":"2","author":"Gandapur Y","year":"2016","unstructured":"Gandapur Y, Kianoush S, Kelli HM, et al.. The role of mHealth for improving medication adherence in patients with cardiovascular disease: a systematic review. Eur Heart J Qual Care Clin Outcomes. 2016, 2:237-44. 10.1093\/ehjqcco\/qcw018","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1111\/ijpp.12242","article-title":"A systematic review of electronic multi-compartment medication devices with reminder systems for improving adherence to self-administered medications","volume":"25","author":"Paterson M","year":"2017","unstructured":"Paterson M, Kinnear M, Bond C, McKinstry B. A systematic review of electronic multi-compartment medication devices with reminder systems for improving adherence to self-administered medications. Int J Pharm Pract. 2017, 25:185-94. 10.1111\/ijpp.12242","journal-title":"Int J Pharm Pract"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-011-1704-y","article-title":"Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis","volume":"26","author":"Grenard JL","year":"2011","unstructured":"Grenard JL, Munjas BA, Adams JL, Suttorp M, Maglione M, McGlynn EA, Gellad WF. Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med. 2011, 26:1175-82. 10.1007\/s11606-011-1704-y","journal-title":"J Gen Intern Med"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2016.08.005","article-title":"Adherence to antihypertensive therapy","volume":"101","author":"Peacock E","year":"2017","unstructured":"Peacock E, Krousel-Wood M. Adherence to antihypertensive therapy. Med Clin North Am. 2017, 101:229-45. 10.1016\/j.mcna.2016.08.005","journal-title":"Med Clin North Am"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws233","article-title":"Life events, coping, and antihypertensive medication adherence among older adults: the cohort study of medication adherence among older adults","volume":"176","author":"Holt EW","year":"2012","unstructured":"Holt EW, Muntner P, Joyce C, Morisky DE, Webber LS, Krousel-Wood M. Life events, coping, and antihypertensive medication adherence among older adults: the cohort study of medication adherence among older adults. Am J Epidemiol. 2012, 176:S64-71. 10.1093\/aje\/kws233","journal-title":"Am J Epidemiol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1186\/s13690-019-0366-9","article-title":"Adherence to antihypertensive medication in Russia: a scoping review of studies on levels, determinants and intervention strategies published between 2000 and 2017","volume":"77","author":"Bochkareva EV","year":"2019","unstructured":"Bochkareva EV, Butina EK, Kim IV, Kontsevaya AV, Drapkina OM, Leon D, McKee M. Adherence to antihypertensive medication in Russia: a scoping review of studies on levels, determinants and intervention strategies published between 2000 and 2017. Arch Public Health. 2019, 77:43. 10.1186\/s13690-019-0366-9","journal-title":"Arch Public Health"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2015.02.007","article-title":"Application of the health belief model to improve the understanding of antihypertensive medication adherence among Chinese patients","volume":"98","author":"Yue Z","year":"2015","unstructured":"Yue Z, Li C, Weilin Q, Bin W. Application of the health belief model to improve the understanding of antihypertensive medication adherence among Chinese patients. Patient Educ Couns. 2015, 98:669-73. 10.1016\/j.pec.2015.02.007","journal-title":"Patient Educ Couns"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1177\/1090198107309459","article-title":"Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans","volume":"36","author":"Schoenthaler A","year":"2009","unstructured":"Schoenthaler A, Ogedegbe G, Allegrante JP. Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans. Health Educ Behav. 2009, 36:127-37. 10.1177\/1090198107309459","journal-title":"Health Educ Behav"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2005.09.002","article-title":"The mediating role of health beliefs in the relationship between depressive symptoms and medication adherence in persons with diabetes","volume":"1","author":"Chao J","year":"2005","unstructured":"Chao J, Nau DP, Aikens JE, Taylor SD. The mediating role of health beliefs in the relationship between depressive symptoms and medication adherence in persons with diabetes. Res Social Adm Pharm. 2005, 1:508-25. 10.1016\/j.sapharm.2005.09.002","journal-title":"Res Social Adm Pharm"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.5380\/ce.v26i0.70402","article-title":"Adherence to antihypertensive treatment in elderly people with cognitive impairment: systematic review (Article in Portuguese)","volume":"4","author":"Alencar Luz AL","year":"2021","unstructured":"Alencar Luz AL, Griep RH, Landim MB, Alencar DD, Macedo JB. Adherence to antihypertensive treatment in elderly people with cognitive impairment: systematic review (Article in Portuguese). Revista Cogitare Enferm. 2021, 4:2-4. 10.5380\/ce.v26i0.70402","journal-title":"Revista Cogitare Enferm"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1370\/afm.843","article-title":"Integration of depression and hypertension treatment: a pilot, randomized controlled trial","volume":"6","author":"Bogner HR","year":"2008","unstructured":"Bogner HR, de Vries HF. Integration of depression and hypertension treatment: a pilot, randomized controlled trial. Ann Fam Med. 2008, 6:295-301. 10.1370\/afm.843","journal-title":"Ann Fam Med"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.2174\/1573402114666181022152313","article-title":"Conceptual model of medication adherence in older adults with high blood pressure-an integrative review of the literature","volume":"15","author":"Oori MJ","year":"2019","unstructured":"Oori MJ, Mohammadi F, Norouzi K, Fallahi-Khoshknab M, Ebadi A. Conceptual model of medication adherence in older adults with high blood pressure-an integrative review of the literature. Curr Hypertens Rev. 2019, 15:85-92. 10.2174\/1573402114666181022152313","journal-title":"Curr Hypertens Rev"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.8.847","article-title":"Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use","volume":"167","author":"Brookhart MA","year":"2007","unstructured":"Brookhart MA, Patrick AR, Schneeweiss S, et al.. Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use. Arch Intern Med. 2007, 167:847-52. 10.1001\/archinte.167.8.847","journal-title":"Arch Intern Med"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00233","article-title":"Disentangling rheumatoid arthritis patients' implicit and explicit attitudes toward methotrexate","volume":"7","author":"Linn AJ","year":"2016","unstructured":"Linn AJ, Vandeberg L, Wennekers AM, Vervloet M, van Dijk L, van den Bemt BJ. Disentangling rheumatoid arthritis patients' implicit and explicit attitudes toward methotrexate. Front Pharmacol. 2016, 7:233. 10.3389\/fphar.2016.00233","journal-title":"Front Pharmacol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2009.04.011","article-title":"Implicit versus explicit attitudes toward psychiatric medication: implications for insight and treatment adherence","volume":"112","author":"R\u00fcsch N","year":"2009","unstructured":"R\u00fcsch N, Todd AR, Bodenhausen GV, Weiden PJ, Corrigan PW. Implicit versus explicit attitudes toward psychiatric medication: implications for insight and treatment adherence. Schizophr Res. 2009, 112:119-22. 10.1016\/j.schres.2009.04.011","journal-title":"Schizophr Res"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.650","article-title":"US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008","volume":"303","author":"Egan BM","year":"2010","unstructured":"Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010, 303:2043-50. 10.1001\/jama.2010.650","journal-title":"JAMA"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg L","year":"2005","unstructured":"Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005, 353:487-97. 10.1056\/NEJMra050100","journal-title":"N Engl J Med"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.983874","article-title":"Meta-analysis: impact of drug class on adherence to antihypertensives","volume":"123","author":"Kronish IM","year":"2011","unstructured":"Kronish IM, Woodward M, Sergie Z, Ogedegbe G, Falzon L, Mann DM. Meta-analysis: impact of drug class on adherence to antihypertensives. Circulation. 2011, 123:1611-21. 10.1161\/CIRCULATIONAHA.110.983874","journal-title":"Circulation"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.06.263","article-title":"Medication adherence and persistence according to different antihypertensive drug classes: a retrospective cohort study of 255,500 patients","volume":"220","author":"Schulz M","year":"2016","unstructured":"Schulz M, Krueger K, Schuessel K, Friedland K, Laufs U, Mueller WE, Ude M. Medication adherence and persistence according to different antihypertensive drug classes: a retrospective cohort study of 255,500 patients. Int J Cardiol. 2016, 220:668-76. 10.1016\/j.ijcard.2016.06.263","journal-title":"Int J Cardiol"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001382","article-title":"Exploring factors associated with patients' adherence to antihypertensive drugs among people with primary hypertension in the United Kingdom","volume":"35","author":"Kurdi AI","year":"2017","unstructured":"Kurdi AI, Chen LC, Elliott RA. Exploring factors associated with patients' adherence to antihypertensive drugs among people with primary hypertension in the United Kingdom. J Hypertens. 2017, 35:1881-90. 10.1097\/HJH.0000000000001382","journal-title":"J Hypertens"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S24752","article-title":"A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence","volume":"6","author":"Barbosa CD","year":"2012","unstructured":"Barbosa CD, Balp MM, Kulich K, Germain N, Rofail D. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence. 2012, 6:39-48. 10.2147\/PPA.S24752","journal-title":"Patient Prefer Adherence"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.18549\/PharmPract.2021.2.2300","article-title":"The association between social support and medication adherence in patients with hypertension: a systematic review","volume":"19","author":"Shahin W","year":"2021","unstructured":"Shahin W, Kennedy GA, Stupans I. The association between social support and medication adherence in patients with hypertension: a systematic review. Pharm Pract (Granada). 2021, 19:2300. 10.18549\/PharmPract.2021.2.2300","journal-title":"Pharm Pract (Granada)"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903192223","article-title":"Generic substitution: additional challenge for adherence in hypertensive patients?","volume":"25","author":"H\u00e5konsen H","year":"2009","unstructured":"H\u00e5konsen H, Eilertsen M, Borge H, Toverud EL. Generic substitution: additional challenge for adherence in hypertensive patients?. Curr Med Res Opin. 2009, 25:2515-21. 10.1185\/03007990903192223","journal-title":"Curr Med Res Opin"},{"key":"ref93","article-title":"Why do the same drugs look different? Pills, trade dress, and public health","volume":"365","author":"Greene JA","year":"2021","unstructured":"Greene JA, Kesselheim AS. Why do the same drugs look different? Pills, trade dress, and public health. N Engl J Med. 2021, 365:54-6.","journal-title":"N Engl J Med"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-013-9885-6","article-title":"Look alike\/sound alike drugs: a literature review on causes and solutions","volume":"36","author":"Ciociano N","year":"2014","unstructured":"Ciociano N, Bagnasco L. Look alike\/sound alike drugs: a literature review on causes and solutions. Int J Clin Pharm. 2014, 36:233-42. 10.1007\/s11096-013-9885-6","journal-title":"Int J Clin Pharm"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.176859","article-title":"Predictors of decline in medication adherence: results from the cohort study of medication adherence among older adults","volume":"58","author":"Krousel-Wood M","year":"2011","unstructured":"Krousel-Wood M, Joyce C, Holt E, et al.. Predictors of decline in medication adherence: results from the cohort study of medication adherence among older adults. Hypertension. 2011, 58:804-10. 10.1161\/HYPERTENSIONAHA.111.176859","journal-title":"Hypertension"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1097\/01.hco.0000126978.03828.9e","article-title":"Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients","volume":"19","author":"Krousel-Wood M","year":"2004","unstructured":"Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004, 19:357-62. 10.1097\/01.hco.0000126978.03828.9e","journal-title":"Curr Opin Cardiol"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-013-9869-6","article-title":"How do we better translate adherence research into improvements in patient care?","volume":"36","author":"La Caze A","year":"2014","unstructured":"La Caze A, Gujral G, Cottrell WN. How do we better translate adherence research into improvements in patient care?. Int J Clin Pharm. 2014, 36:10-4. 10.1007\/s11096-013-9869-6","journal-title":"Int J Clin Pharm"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/249253-adherence-to-antihypertensive-therapy-and-its-determinants-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T13:16:37Z","timestamp":1714655797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/249253-adherence-to-antihypertensive-therapy-and-its-determinants-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":97,"URL":"https:\/\/doi.org\/10.7759\/cureus.59532","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,2]]}}}